[1] Zhao Y,Wei D,Zhang Y,et al.Panoramic view of microRNAs in regulating cancer stem cells [J].Essays in biochemistry,2022,66(4):345-358. [2] Saleh A A,Soliman S E,Habib M S E,et al.Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer [J].Molecular biology reports,2019,46(3):2809-2818. [3] Lagos-quintana M,Rauhut R,Yalcin A,et al.Identification of tissue-specific microRNAs from mouse [J].Current biology:CB,2002,12(9):735-739. [4] Li K W,Wang S H,Wei X,et al.Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene [J].European review for medical and pharmacological sciences,2020,24(24):12655-12666. [5] Wang W,Yang J,Yu F,et al.MicroRNA-122-3p inhibits tumor cell proliferation and induces apoptosis by targeting Forkhead box O in A549 cells [J].Oncology letters,2018,15(2):2695-2699. [6] Song A L,Zhao L,Wang Y W,et al.Chemoresistance in gastric cancer is attributed to the overexpression of excision repair cross-complementing 1 (ERCC1) caused by microRNA-122 dysregulation [J].Journal of cellular physiology,2019,234(12):22485-22492. [7] Zhang Y,Huang H,Zhang Y,et al.Combined detection of serum MiR-221-3p and MiR-122-5p expression in diagnosis and prognosis of gastric cancer [J].Journal of gastric cancer,2019,19(3):315-328. [8] Xu X,Gao F,Wang J,et al.MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4 [J].Cancer biology & therapy,2018,19(5):427-435. [9] Meng L,Chen Z,Jiang Z,et al.MiR-122-5p suppresses the proliferation,migration,and invasion of gastric cancer cells by targeting LYN [J].Acta biochimica et biophysica Sinica,2020,52(1):49-57. [10] Vogel A,Meyer T,Sapisochin G,et al.Hepatocellular carcinoma [J].Lancet (London,England),2022,400(10360):1345-1362. [11] Zhao Z,Gao J,Huang S.LncRNA SNHG7 promotes the HCC progression through miR-122-5p/FOXK2 axis [J].Digestive diseases and sciences,2022,67(3):925-935. [12] Li X N,Yang H,Yang T.miR-122 inhibits hepatocarcinoma cell progression by targeting LMNB2 [J].Oncol Res,2020,28(1):41-49. [13] Wei X,Liu H,Li X,et al.Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4 [J].Annals of hepatology,2019,18(6):869-878. [14] Chen F,Li Y,Aye L,et al.FUT8 is regulated by miR-122-5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling [J].Cellular oncology (Dordrecht),2023,46(1):79-91. [15] Baidoun F,Elshiwy K,Elkeraie Y,et al.Colorectal cancer epidemiology:recent trends and impact on outcomes [J].Current drug targets,2021,22(9):998-1009. [16] Sendi H,Yazdimamaghani M,Hu M,et al.Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis [J].Cancer Res,2022,82(1):105-113. [17] Wang X,Zhang H,Yang H,et al.Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer [J].Molecular oncology,2020,14(3):539-555. [18] Xiong Q,Bai Y,Shi R,et al.Preferentially released miR-122 from cyclodextrin-based star copolymer nanoparticle enhances hepatoma chemotherapy by apoptosis induction and cytotoxics efflux inhibition [J].Bioactive materials,2021,6(11):3744-3755.
2023, Vol. 29 
冀公网安备13080202000677号